发明名称 |
CYTOKINE DERIVED TREATMENT WITH REDUCED VASCULAR LEAK SYNDROME |
摘要 |
The present invention relates to a pharmaceutical composition for treating a cancer or an infection in a subject by administrating an amount of an IL-15 derivative conjugate so as to induce a proliferation of natural killer cells (NK cells) which is the same or higher than the one obtained with high dose of interleukin-2 (HDIL-2); eventually associated with a pharmaceutically acceptable carrier. |
申请公布号 |
EP2986312(A1) |
申请公布日期 |
2016.02.24 |
申请号 |
EP20140723324 |
申请日期 |
2014.04.22 |
申请人 |
CYTUNE PHARMA;INSTITUT GUSTAVE ROUSSY (IGR) |
发明人 |
BECHARD, DAVID;CHAPUT, NATHALIE;DESBOIS, MELANIE |
分类号 |
A61K38/20;A61K47/48;A61P31/00;A61P35/00;A61P37/04;G01N33/50 |
主分类号 |
A61K38/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|